Ryan Bender

1.8k total citations
39 papers, 1.2k citations indexed

About

Ryan Bender is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Ryan Bender has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Ryan Bender's work include Cancer Genomics and Diagnostics (10 papers), Cancer therapeutics and mechanisms (8 papers) and Lung Cancer Treatments and Mutations (4 papers). Ryan Bender is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Cancer therapeutics and mechanisms (8 papers) and Lung Cancer Treatments and Mutations (4 papers). Ryan Bender collaborates with scholars based in United States, Bosnia and Herzegovina and Italy. Ryan Bender's co-authors include Neil Osheroff, Zoran Gatalica, Sherri Z. Millis, R. Hunter Lindsey, Semir Vranić, Gargi D. Basu, Andreas Voß, Gerald C. Chu, Giannicola Genovese and Florian L. Müller and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Ryan Bender

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan Bender United States 19 606 494 190 170 160 39 1.2k
Lucille Leong United States 23 502 0.8× 691 1.4× 162 0.9× 170 1.0× 265 1.7× 74 1.6k
Douglas Bootle Switzerland 13 718 1.2× 582 1.2× 96 0.5× 150 0.9× 304 1.9× 17 1.2k
G. Dark United Kingdom 14 558 0.9× 476 1.0× 111 0.6× 265 1.6× 334 2.1× 28 1.4k
M de Boer-Dennert Netherlands 18 627 1.0× 806 1.6× 153 0.8× 62 0.4× 197 1.2× 30 1.5k
Dineo Khabele United States 22 847 1.4× 450 0.9× 121 0.6× 168 1.0× 96 0.6× 54 1.6k
Man‐Hsin Hung Taiwan 21 537 0.9× 488 1.0× 149 0.8× 232 1.4× 273 1.7× 45 1.4k
Danijela Jelovac United States 24 921 1.5× 913 1.8× 121 0.6× 465 2.7× 294 1.8× 51 2.2k
Franklin C. Harwood United States 16 919 1.5× 547 1.1× 131 0.7× 144 0.8× 168 1.1× 17 1.4k
Akihiko Suto Japan 15 285 0.5× 503 1.0× 136 0.7× 190 1.1× 188 1.2× 63 945
Isabelle Hennebelle France 19 506 0.8× 726 1.5× 97 0.5× 106 0.6× 188 1.2× 25 1.1k

Countries citing papers authored by Ryan Bender

Since Specialization
Citations

This map shows the geographic impact of Ryan Bender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Bender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Bender more than expected).

Fields of papers citing papers by Ryan Bender

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Bender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Bender. The network helps show where Ryan Bender may publish in the future.

Co-authorship network of co-authors of Ryan Bender

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Bender. A scholar is included among the top collaborators of Ryan Bender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Bender. Ryan Bender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Arguello, David, Andreas Voß, Zoran Gatalica, & Ryan Bender. (2016). O.04: Profiling of MET-Amplified Non-Small Cell Lung Cancer (NSCLC), Correlation to cMET Protein Expression/MET Exon 14 Skipping. Journal of Thoracic Oncology. 11(10). S170–S170. 1 indexed citations
4.
Friedländer, Michael, Kenneth Russell, Sherri Z. Millis, et al.. (2016). Molecular Profiling of Clear Cell Ovarian Cancers. International Journal of Gynecological Cancer. 26(4). 648–654. 67 indexed citations
5.
Feldman, Rebecca, Zoran Gatalica, Semir Vranić, et al.. (2016). Abstract 3928: Caveolin-1: Beyond a marker for basal-like breast cancers. Cancer Research. 76(14_Supplement). 3928–3928. 1 indexed citations
6.
Vranić, Semir, Caterina Marchiò, Isabella Castellano, et al.. (2015). Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast. Human Pathology. 46(9). 1350–1359. 38 indexed citations
7.
Wen, Wenhsiang, Wangjuh Chen, Ryan Bender, et al.. (2015). Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers. Journal of Molecular Diagnostics. 17(5). 487–495. 53 indexed citations
8.
Gatalica, Zoran, Nurija Bilalović, Juan Palazzo, et al.. (2015). Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1. Oncotarget. 6(23). 19819–19825. 67 indexed citations
9.
Sirintrapun, S. Joseph, Kim R. Geisinger, Anthony N. Snow, et al.. (2014). Oncocytoma-Like Renal Tumor With Transformation Toward High-Grade Oncocytic Carcinoma. Medicine. 93(15). e81–e81. 4 indexed citations
10.
Bender, Ryan, et al.. (2014). Thermal Modeling of Tissue Ablation During Pulsed CO2 Laser Gingivectomy for Gum Reshaping and Reduction. The Annals of Thoracic Surgery. 92(2). 632–7. 1 indexed citations
11.
Millis, Sherri Z., David Bryant, Gargi D. Basu, et al.. (2014). Molecular Profiling of Infiltrating Urothelial Carcinoma of Bladder and Nonbladder Origin. Clinical Genitourinary Cancer. 13(1). e37–e49. 53 indexed citations
12.
Millis, Sherri Z., David Bryant, Gargi D. Basu, et al.. (2014). Molecular profiling of infiltrating urothelial carcinoma of the bladder.. Journal of Clinical Oncology. 32(4_suppl). 311–311. 1 indexed citations
13.
Gatalica, Zoran, Sherri Z. Millis, Semir Vranić, et al.. (2014). Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: Analysis of 1806 cases. Oncotarget. 5(23). 12440–12447. 56 indexed citations
14.
Miller, Keva M., et al.. (2013). Individual and systemic/structural bias in child welfare decision making: Implications for children and families of color. Children and Youth Services Review. 35(9). 1634–1642. 49 indexed citations
15.
Bender, Ryan, et al.. (2013). Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi. Modern Pathology. 26(10). 1320–1328. 30 indexed citations
16.
Kwong, Lawrence N., James C. Costello, Huiyun Liu, et al.. (2012). Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma. Nature Medicine. 18(10). 1503–1510. 274 indexed citations
17.
Kuroda, Naoto, Māris Sperga, Federico A. Monzon, et al.. (2012). Juxtaglomerular cell tumor: A morphological, immunohistochemical and genetic study of six cases. Human Pathology. 44(1). 47–54. 28 indexed citations
18.
Basu, Gargi D., Anatole Ghazalpour, Raheela Ashfaq, et al.. (2011). Frequency distribution of SPARC in triple-negative breast cancer patients.. Journal of Clinical Oncology. 29(27_suppl). 37–37. 3 indexed citations
19.
Lindsey, R. Hunter, Ryan Bender, & Neil Osheroff. (2005). Stimulation of topoisomerase II-mediated DNA cleavage by benzene metabolites. Chemico-Biological Interactions. 153-154. 197–205. 33 indexed citations
20.
Bender, Ryan, R. Hunter Lindsey, D. Andrew Burden, & Neil Osheroff. (2004). N-Acetyl-p-benzoquinone Imine, the Toxic Metabolite of Acetaminophen, Is a Topoisomerase II Poison. Biochemistry. 43(12). 3731–3739. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucille Leong Breakdown of academic impact, for papers by Douglas Bootle Breakdown of academic impact, for papers by G. Dark Breakdown of academic impact, for papers by M de Boer-Dennert Breakdown of academic impact, for papers by Dineo Khabele Breakdown of academic impact, for papers by Man‐Hsin Hung Breakdown of academic impact, for papers by Danijela Jelovac Breakdown of academic impact, for papers by Franklin C. Harwood Breakdown of academic impact, for papers by Akihiko Suto Breakdown of academic impact, for papers by Isabelle Hennebelle
Rankless by CCL
2026